Yves Aubin, Ph,D., a research scientist at the Biologics and Genetics Therapies Directorate, Health Canada, describes the use of nuclear magnetic resonance (NMR) spectroscopy for the characterization of protein therapeutics and polysaccharide vaccines. Yves is responsible for regulation of biologics products to ensure their safety and efficacy.